연구
교육
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Institute for Applied Informatics
Markus Reischl has not added Biography.
If you are Markus Reischl and would like to personalize this page please email our Author Liaison for assistance.
Biomedizinische Technik. Biomedical engineering Dec, 2006 | Pubmed ID: 17155862
Reproductive toxicology (Elmsford, N.Y.) Sep, 2009 | Pubmed ID: 19406227
Nature methods Dec, 2009 | Pubmed ID: 19898487
Proceedings of the National Academy of Sciences of the United States of America Feb, 2010 | Pubmed ID: 20133847
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Aug, 2010 | Pubmed ID: 20473283
Histopathology Jun, 2010 | Pubmed ID: 20636794
Biomedizinische Technik. Biomedical engineering Feb, 2011 | Pubmed ID: 21210758
SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Human pathology Aug, 2011 | Pubmed ID: 21334718
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Jul, 2011 | Pubmed ID: 21460799
Lung cancer (Amsterdam, Netherlands) Oct, 2011 | Pubmed ID: 21477882
PloS one , 2011 | Pubmed ID: 21655100
Histopathology Jun, 2011 | Pubmed ID: 21707704
Journal of cell science Feb, 2012 | Pubmed ID: 22331361
Karlsruhe Institute of Technology, Karlsruhe, Germany
Christine Wittmann1,
Markus Reischl2,
Asmi H. Shah1,
Ralf Mikut2,
Urban Liebel1,2,
Clemens Grabher1
1Institute for Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany,
2Institute for Applied Informatics, Karlsruhe Institute of Technology, Karlsruhe, Germany
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유